Lilan Xin
Impact in
- Organic Chemistry top 10%
- Catalytic C–H Functionalization Methods
- Radical Photochemical Reactions
- Sulfur-Based Synthesis Techniques
- Synthesis and Catalytic Reactions
- Oxidative Organic Chemistry Reactions
Papers in
-
- Protein Degradation and Inhibitors 10
- Ubiquitin and proteasome pathways 7
- Histone Deacetylase Inhibitors Research 3
- Oncology 6
- Peptidase Inhibition and Analysis 5
- Co-authors
- Kun Xu (3 shared papers)Huiqiao Wang (2 shared papers)Wenmin Liu (2 shared papers)Sheng Zhang (2 shared papers)Zhiqiang Wang (1 shared paper)Hai‐Bing Zhou (14 shared papers)Wentao Xu (1 shared paper)Jinjin Zhang (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lilan Xin
17 papers receiving 301 citations
Peers
Comparison fields: 5 of 39
- Organic Chemistry 193
- Toxicology 7
- Hematology 20
- Molecular Biology 114
- Oncology 35
Countries citing papers authored by Lilan Xin
This map shows the geographic impact of Lilan Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilan Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilan Xin more than expected).
Fields of papers citing papers by Lilan Xin
This network shows the impact of papers produced by Lilan Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilan Xin. The network helps show where Lilan Xin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lilan Xin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 74 | |
| 2 | 2018 | 71 | |
| 3 | 2017 | 27 | |
| 4 | 2024 | 20 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 13 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2024 | 10 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2022 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 |
About Lilan Xin
Lilan Xin is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Genetics and Hematology, having authored 18 papers that have together received 302 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (10 papers), Ubiquitin and proteasome pathways (7 papers), Estrogen and related hormone effects (5 papers), Peptidase Inhibition and Analysis (5 papers), Histone Deacetylase Inhibitors Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Catalytic C–H Functionalization Methods (3 papers) and Sulfur-Based Synthesis Techniques (3 papers). The work is most often cited by research in Organic Chemistry (193 citations), Toxicology (7 citations), Hematology (20 citations), Molecular Biology (114 citations) and Oncology (35 citations). Lilan Xin has collaborated with scholars based in China and United States. Frequent co-authors include Kun Xu, Huiqiao Wang, Wenmin Liu, Sheng Zhang, Zhiqiang Wang, Hai‐Bing Zhou, Wentao Xu, Jinjin Zhang, Yaping Li and Chune Dong. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.